Duquesne Capital Management appeared to be the VC, which was created in 1981.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Duquesne Capital Management, startups are often financed by Talu Ventures, Motorola Solutions Venture Capital, Deutsche Bank. The meaningful sponsors for the fund in investment in the same round are Galleon Group, Tollgrade Communications, Telkonet. In the next rounds fund is usually obtained by Morgan Stanley, International Finance Corporation, Innovation Works.
Speaking about the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this Duquesne Capital Management performs on 71 percentage points more the average number of lead investments. The top amount of exits for fund were in 2007. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2007. The common things for fund are deals in the range of 50 - 100 millions dollars.
The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Digital Media. Among the most popular portfolio startups of the fund, we may highlight FibroGen, Dilithium Networks, BPL Global.
| Fund Name | Location |
| ACN | Concord, North Carolina, United States |
| Centre for the Development of Industrial Technology (CDTI) | Madrid, Madrid, Spain |
| Coriant America | Chelmsford, Massachusetts, United States |
| Emles Venture Partners | - |
| Fi Capital | Beijing, Beijing, China |
| Groupe Casino | France, Rhone-Alpes, Saint Etienne |
| IDEO CoLab Ventures | Cambridge, Massachusetts, United States |
| IRPC Public Company | Bangkok, Krung Thep, Thailand |
| KLUB Works | - |
| LAC | Japan, Tokyo |
| Qiu Zhang Dian Zi | China, Shanghai |
| Rockefeller Financial Services | California, Los Angeles, United States |
| Samwhan Corporation | - |
| Shanghai Jianxin Kangying Venture Capital Management | China, Shanghai |
| Taurus Ventures | California, San Francisco, United States |
| Tern | England, London, United Kingdom |
| Thermo Fisher Scientific | Massachusetts, United States, Waltham |
| Unicorn Capital Partners | China, Hong Kong, Hong Kong Island |
| VentureCrowd | Australia, New South Wales, Sydney |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ratio Therapeutics | $50M | 17 Jan 2024 | Boston, Massachusetts, United States | ||
Ratio Therapeutics | $20M | 01 Feb 2023 | Boston, Massachusetts, United States | ||
BPL Global | $26M | 15 Feb 2007 | Pennsylvania, United States | ||
Synta Pharmaceuticals | $50M | 14 Jan 2004 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ratio Therapeutics | $50M | 17 Jan 2024 | Boston, Massachusetts, United States | ||
Ratio Therapeutics | $20M | 01 Feb 2023 | Boston, Massachusetts, United States | ||
BPL Global | $26M | 15 Feb 2007 | Pennsylvania, United States | ||
Synta Pharmaceuticals | $50M | 14 Jan 2004 | Massachusetts, United States |
